Clinical trial

Kidneys
#Clinical trial #Kidney disease #Nephrology #Takeda #Vera Therapeutics

Positive news for IgAN treatment presented at Kidney Week

Positive data from two trials in immunoglobulin A nephropathy (IgAN) were shared at the American Society of Nephrology Kidney Week 2024 in San Diego, California. Vera Therapeutics announced data from its ORIGIN Phase IIb trial of atacicept that showed stabilised kidney function through 96 weeks of… Read More

#News #Trending News

Monoclonal antibody
#Cancer Research UK #Clinical trial #Monoclonal antibodies #Oncology #UCB

Monoclonal antibody targets HLA-G in advanced cancers

A new clinical trial has launched to assess monoclonal antibody UCB4594 in people with advanced cancers. The first site for the study has opened at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust (The… Read More

#Cancer Research #News

CT scans of the brain
#Alzheimer's #Clinical trial #Dementia #UK

Accelerator to boost dementia clinical trial participation in UK 

A new initiative hopes to increase the number of people participating in dementia clinical trials in the UK, aiming to identify tens of thousands of potential trial participants.  The new ‘Dementia Trials Accelerator’ initiative hopes to address pharma-identified roadblocks to the delivery of commercial clinical trials in… Read More

#News

Professor Glenn King working in the lab with a funnel web spider. Credit The University of Queensland
#Clinical trial #Heart attack #Heart disease #Medical Research Future Fund #University of Queensland

Spider venom heart drug moves to human clinical trials

A project to develop a drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF). Professor Glenn King from the University of Queensland’s (UQ) Institute for Molecular Bioscience… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

New DDW Highlights podcast: 10 September 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the release of clinical study results that led some media titles to ask… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

New DDW Highlights vodcast: 10 September 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   With the release of clinical… Read More

#News

#Clinical trial #Clinical trials #GLP-1 #Phase I trial #Phase II trial

This week in drug discovery (2-6 September) 

News round-up for 2-6 September by DDW Senior Digital Content Editor Diana Spencer. With the release of clinical study results that led some media titles to ask if semaglutide could be a ‘fountain of youth’, this week our news highlights focus on clinical trials at a variety of… Read More

#News

Brain physiology
#AGuIX #Cancer research #Clinical trial #Dana-Farber Cancer Institute #Drug discovery #Neuroscience

Phase II brain metastases trial advances after futility analysis 

The Phase II NANOBRAINMETS trial of AGuIX has been validated by the Data Safety and Monitoring Board (DSMB) following a futility analysis scheduled after the enrolment and follow-up of 50% of patients in the study.  The trial is being run by NH TherAguix, a biotechnology company developing… Read More

#Cancer Research #News

Urticaria or hives
#Clinical trial #Dermatology #Evommune #Phase II trial

Clinical trial investigates oral MRGPRX2 antagonist in urticaria

The first patient has been treated in a Phase II trial of EVO756 in adults with chronic inducible urticaria (CIndU). EVO756 is a highly selective small molecule antagonist of mas-related G-protein coupled receptor X2 (MRGPRX2) and could offer the potential for once-daily oral administration without the… Read More

#News

#Clinical trial #Colorectal cancer #NuCana #Oncology

Colorectal cancer study to be discontinued

NuCana has revealed that the NuTide:323 colorectal cancer study is being discontinued following a pre-planned initial analysis and recommendation from the NuTide:323 Study Steering Committee. The Steering Committee believed that the combination of NUC-3373 with leucovorin, irinotecan and bevacizumab (NUFIRI+bev) was unlikely to achieve the study’s… Read More

#News

Lungs
#Autoimmune disease #Clinical trial #GSK #Interview #Lung disease

GSK’s autoimmune efforts

DDW Editor Reece Armstrong speaks to Roger Levy, Global Medical Expert Immunology & Specialty Medicine at GSK about the company’s work into treating systemic sclerosis-associated interstitial lung disease and its recent BLISSc-ILD study evaluating its belimumab treatment.  RA: Can you give us an overview of the BLISSc-ILD study? RL: The BLISSc-ILD study… Read More

#Exclusive Content

#AAV #Clinical trial #Duchenne muscular dystrophy #Gene therapy #REGENXBIO

Positive Phase I/II trial data for Duchenne gene therapy

New data has revealed a robust microdystrophin expression from a pivotal dose of gene therapy RGX-202 for Duchenne muscular dystrophy (Duchenne). RGX-202 is an investigational one-time AAV therapeutic designed to deliver a novel microdystrophin gene that includes key regions of the naturally occurring dystrophin gene. Read More

#News

Colourised scanning electron micrograph of Marburg virus particles
#Clinical trial #Immunology / Virology & Vaccines #University of Oxford #Vaccine candidate

First-in-human vaccine trial for deadly Marburg virus

Scientists at the University of Oxford in the UK have launched a new clinical trial to test a vaccine to protect against “devastating” Marburg virus. This is the first-in-human trial of the ChAdOx1 Marburg vaccine, which has been developed and manufactured by researchers at the University… Read More

#News #Trending News

Enterovirus
#Clinical trial #Monoclonal antibodies #National Institutes of Health (NIH) #Virology

Trial to test monoclonal antibody for virus of growing concern

The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and neurological diseases such as acute flaccid myelitis (AFM). AFM has emerged in the United States… Read More

#News #Trending News

MRI of the brain showing glioblastoma
#Brain cancer #Clinical trial #Drug repurposing #HIV #Oncology #University of Plymouth

Clinical trial to repurpose HIV drugs to treat brain tumours

Drugs developed to treat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours. Scientists at the Brain Tumour Research Centre of Excellence at the University of Plymouth are conducting a clinical trial to see whether using anti-retroviral medications, ritonavir… Read More

#Cancer Research #Editor's Choice #News